Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Suppes

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
The Journal of Clinical Psychiatry|December 6, 2000
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study GroupJ R Calabrese, T Suppes, C L Bowden, et al.
Bipolar Disorders|March 21, 2001
Gabapentin in the acute treatment of refractory bipolar disorderL L Altshuler, P E Keck, S L McElroy, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
Psychological Medicine|February 20, 2004
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluationM H Trivedi, A J Rush, H M Ibrahim, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
The Journal of Clinical Psychiatry|December 6, 2000
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study GroupJ R Calabrese, T Suppes, C L Bowden, et al.
Bipolar Disorders|March 21, 2001
Gabapentin in the acute treatment of refractory bipolar disorderL L Altshuler, P E Keck, S L McElroy, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
Psychological Medicine|February 20, 2004
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluationM H Trivedi, A J Rush, H M Ibrahim, et al.
Pageof 8